Calamos Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $284M | Buy |
308,497
+35,943
| +13% | +$36.4M | 1.01% | 15 |
|
|
2025
Q4 | $293M | Sell |
272,554
-1,759
| -0.6% | -$1.68M | 1.1% | 14 |
|
|
2025
Q3 | $209M | Sell |
274,313
-4,255
| -2% | -$3.17M | 0.77% | 20 |
|
|
2025
Q2 | $217M | Buy |
278,568
+5,462
| +2% | +$4.24M | 0.85% | 15 |
|
|
2025
Q1 | $226M | Sell |
273,106
-18,870
| -6% | -$15.7M | 0.98% | 14 |
|
|
2024
Q4 | $225M | Buy |
291,976
+3,433
| +1% | +$2.84M | 0.94% | 14 |
|
|
2024
Q3 | $256M | Sell |
288,543
-42,859
| -13% | -$38.5M | 1.11% | 10 |
|
|
2024
Q2 | $300M | Sell |
331,402
-6,332
| -2% | -$5.07M | 1.33% | 11 |
|
|
2024
Q1 | $263M | Sell |
337,734
-36,110
| -10% | -$25.7M | 1.24% | 8 |
|
|
2023
Q4 | $218M | Sell |
373,844
-2,892
| -0.8% | -$1.69M | 1.06% | 9 |
|
|
2023
Q3 | $202M | Sell |
376,736
-10,119
| -3% | -$5.21M | 1.05% | 11 |
|
|
2023
Q2 | $181M | Sell |
386,855
-28,107
| -7% | -$11.8M | 0.9% | 12 |
|
|
2023
Q1 | $143M | Sell |
414,962
-33,993
| -8% | -$11.5M | 0.7% | 15 |
|
|
2022
Q4 | $164M | Sell |
448,955
-53,957
| -11% | -$19.1M | 0.77% | 12 |
|
|
2022
Q3 | $163M | Buy |
502,912
+6,388
| +1% | +$2.02M | 0.74% | 14 |
|
|
2022
Q2 | $161M | Sell |
496,524
-3,941
| -0.8% | -$1.18M | 0.69% | 15 |
|
|
2022
Q1 | $143M | Buy |
500,465
+14,078
| +3% | +$3.62M | 0.54% | 22 |
|
|
2021
Q4 | $134M | Buy |
486,387
+28,041
| +6% | +$7.11M | 0.5% | 26 |
|
|
2021
Q3 | $106M | Sell |
458,346
-7,972
| -2% | -$1.97M | 0.46% | 33 |
|
|
2021
Q2 | $107M | Buy |
466,318
+67,739
| +17% | +$13.6M | 0.49% | 33 |
|
|
2021
Q1 | $74.5M | Buy |
398,579
+56,221
| +16% | +$11M | 0.41% | 46 |
|
|
2020
Q4 | $57.8M | Sell |
342,358
-17,617
| -5% | -$2.63M | 0.34% | 67 |
|
|
2020
Q3 | $53.3M | Buy |
359,975
+18,125
| +5% | +$2.81M | 0.34% | 65 |
|
|
2020
Q2 | $56.1M | Buy |
341,850
+88,227
| +35% | +$13.5M | 0.4% | 57 |
|
|
2020
Q1 | $35.2M | Sell |
253,623
-11,751
| -4% | -$1.61M | 0.28% | 107 |
|
|
2019
Q4 | $34.9M | Sell |
265,374
-2,577
| -1% | -$299K | 0.17% | 163 |
|
|
2019
Q3 | $30M | Sell |
267,951
-13,782
| -5% | -$1.53M | 0.16% | 176 |
|
|
2019
Q2 | $31.2M | Buy |
281,733
+5,856
| +2% | +$690K | 0.17% | 174 |
|
|
2019
Q1 | $35.8M | Buy |
275,877
+112
| +0% | +$13.6K | 0.22% | 147 |
|
|
2018
Q4 | $31.9M | Buy |
275,765
+20,341
| +8% | +$2.27M | 0.21% | 135 |
|
|
2018
Q3 | $27.4M | Buy |
255,424
+6,841
| +3% | +$684K | 0.15% | 177 |
|
|
2018
Q2 | $21.2M | Buy |
248,583
+13,311
| +6% | +$1.09M | 0.13% | 210 |
|
|
2018
Q1 | $18.2M | Buy |
235,272
+4,729
| +2% | +$381K | 0.12% | 229 |
|
|
2017
Q4 | $19.5M | Sell |
230,543
-167,586
| -42% | -$14.3M | 0.1% | 206 |
|
|
2017
Q3 | $34.1M | Buy |
398,129
+1,998
| +0.5% | +$164K | 0.26% | 116 |
|
|
2017
Q2 | $32.6M | Buy |
396,131
+6,879
| +2% | +$561K | 0.24% | 121 |
|
|
2017
Q1 | $32.7M | Sell |
389,252
-206
| -0.1% | -$16.5K | 0.26% | 110 |
|
|
2016
Q4 | $28.6M | Sell |
389,458
-43,461
| -10% | -$3.24M | 0.23% | 133 |
|
|
2016
Q3 | $34.7M | Buy |
432,919
+97
| +0% | +$7.76K | 0.25% | 130 |
|
|
2016
Q2 | $34.1M | Buy |
432,822
+37
| +0% | +$2.79K | 0.24% | 136 |
|
|
2016
Q1 | $31.2M | Buy |
432,785
+6,148
| +1% | +$465K | 0.21% | 154 |
|
|
2015
Q4 | $35.9M | Hold |
426,637
| – | – | 0.23% | 133 |
|
|
2015
Q3 | $35.7M | Buy |
426,637
+32
| +0% | +$2.7K | 0.25% | 129 |
|
|
2015
Q2 | $35.6M | Sell |
426,605
-14,109
| -3% | -$1.08M | 0.22% | 141 |
|
|
2015
Q1 | $32M | Buy |
440,714
+8,958
| +2% | +$638K | 0.2% | 148 |
|
|
2014
Q4 | $29.8M | Buy |
431,756
+506
| +0.1% | +$34.2K | 0.2% | 139 |
|
|
2014
Q3 | $28M | Hold |
431,250
| – | – | 0.19% | 141 |
|
|
2014
Q2 | $26.8M | Buy |
431,250
+7,000
| +2% | +$418K | 0.17% | 153 |
|
|
2014
Q1 | $25M | Hold |
424,250
| – | – | 0.16% | 166 |
|
|
2013
Q4 | $21.6M | Hold |
424,250
| – | – | 0.14% | 177 |
|
|
2013
Q3 | $21.4M | Buy |
424,250
+90,000
| +27% | +$4.71M | 0.13% | 168 |
|
|
2013
Q2 | $16.4M | Buy |
+334,250
| New | +$18.2M | 0.11% | 190 |
|
Other funds holding LLY
VCM
VPM
Calamos Advisors's LLY Position: Q1 2026 in Review
Calamos Advisors increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $36.4M and bringing the position to 308,497 shares worth $284M. The position accounts for 1.01% of the portfolio, ranked #15.
Calamos Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $300M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Calamos Advisors held 308,497 shares of Eli Lilly worth $284M as of Q1 2026.
- Calamos Advisors bought 35,943 Eli Lilly shares in Q1 2026, an estimated $36.4M.
- Eli Lilly made up 1.01% of Calamos Advisors's portfolio in Q1 2026, its #15 holding.
- Calamos Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's Eli Lilly position peaked at $300M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.